News

Filter

Current filters:

RebifLemtradaAnti-virals

1 to 9 of 95953 results

FDA approves Elelyso for pediatric use in Gaucher disease

29-08-2014

The US Food and Drug Administration has approved US pharma giant Pfizer’s Elelyso (taliglucerase alfa)…

ElelysoPfizerPharmaceuticalProtalix BioTherapeuticsRare diseasesRegulationUSA

Colorectal cancer market will remain steady at $7.7 billion by 2023; report

29-08-2014

The market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023…

EuropeJapanMarkets & MarketingOncologyPharmaceuticalUSA

Tau Therapeutics and Xdynia merge to form Cavion

29-08-2014

Privately-held US drugmakers Tau Therapeutics and Xdynia announced today that they have merged; the surviving…

CavionMergers & AcquisitionsNeurologicalOncologyPharmaceuticalTau TherapeuticsXdynia

India's Piramal will divert resources from early-stage research to advanced-stage molecules

India's Piramal will divert resources from early-stage research to advanced-stage molecules

29-08-2014

Indian pharma company Piramal Enterprises has announced its intention to stop early-stage research in…

IndiaMetabolic disordersPharmaceuticalPiramal EnterprisesPiramal HealthcareProductionResearchSwati PiramalUS Food and Drug Administration

Minomic to reformulate its MIL-38 prostate cancer screening target as a therapy with Catalent

Minomic to reformulate its MIL-38 prostate cancer screening target as a therapy with Catalent

29-08-2014

Australian biotech company Minomic International will join forces with Catalent Pharma to develop its…

AustraliaBiotechnologyCatalent PharmaMinomicOncologyProstate cancerProstate cancer screening technologyResearch

Takeda's 10-year study finds no link between pioglitazone and bladder cancer

Takeda's 10-year study finds no link between pioglitazone and bladder cancer

29-08-2014

Japan’s largest drugmaker Takeda has completed the post-marketing commitment and data submissions to…

Bladder cancerEuropean Medicines AgencyJapanOncologyPharmaceuticalPioglitazoneRegulationResearchTakeda PharmaceuticalsUS Food and Drug Administration

Edison re-evaluates Onconova based on extended rigosertib timeline after trial failure

Edison re-evaluates Onconova based on extended rigosertib timeline after trial failure

29-08-2014

After failing to meet the primary endpoint of its trial of rigosertib (IV), oncology specialist Onconova…

FinancialMyelodysplastic syndromeOncologyOncology specialistOnconova TherapeuticsPharmaceuticalrigosertibUSA

Amgen files for US approval of cholesterol drug evolocumab

28-08-2014

USA-based Amgen, the world's leading independent biotech firm, has filed a Biologics License Application…

AmgenBiotechnologyCardio-vascularevolocumabRegulationUSA

1 to 9 of 95953 results

Back to top